The global medicated shampoo market size was valued at USD 15.24 billion in 2023 and is projected to grow at a CAGR of 4.6% from 2024 to 2030. The medicated shampoo market is driven by factors such as increased consumer awareness of scalp health, rising prevalence of scalp disorders, innovative product launches, and the influence of urbanization, e-commerce, and increasing disposable income on consumer purchasing habits.
Firstly, the increasing awareness of scalp health among consumers is a major driver, as people become more conscious of the importance of scalp health and seek therapeutic solutions to address conditions such as dandruff and psoriasis. This heightened awareness has led to a growing demand for medicated shampoos that offer effective treatment measures.
Product innovation is another key factor driving the market, with continuous advancements in formulations and the introduction of natural and organic ingredients enhancing the effectiveness and appeal of medicated shampoos. The expansion of distribution channels, including online platforms, pharmacies, and specialty stores, has also improved consumer access and convenience, making it easier for people to purchase medicated shampoos. Effective marketing and endorsements by dermatologists have also built consumer trust and awareness, further driving market growth.
Demographic trends are also playing a significant role in driving the market, with an aging population and lifestyle changes contributing to increased scalp health issues. The increasing prevalence of scalp disorders, including dandruff, psoriasis, and seborrheic dermatitis, has also created a need for effective treatment measures. Furthermore, the enhancement of customers' disposable income within the developing economy has enabled them to expend more on luxury hair care products, including medicated shampoos. The increase in online markets for product sales has also facilitated easy access to various medicated shampoos, with convenience home delivery facilities and better prices compared to retail stores being key factors that have fueled sales in this segment.
Dandruff & seborrheic dermatitis treatment dominated the market with a revenue share of 26.2% in 2023. Medicated shampoos feature a range of active compounds, including zinc pyrithione, ketoconazole, and selenium sulfide, which have demonstrated clinical efficacy in treating dandruff and seborrheic dermatitis. Moreover, the growing demand for natural ingredients in personal care products has led to the development of innovative shampoos incorporating botanical extracts alongside conventional active ingredients, catering to consumers seeking natural alternatives with comparable efficacy.
Psoriasis treatment is expected to register significant growth with a CAGR of 4.8% over the forecast period. Psoriasis is a chronic autoimmune condition characterized by rapid skin cell multiplication, leading to thick, red, and scaly skin. Despite its prevalence, the condition's severity varies among individuals. Medicated shampoos featuring coal tar, salicylic acid, and corticosteroids have been clinically proven to reduce inflammation, scaling, and itching associated with psoriasis. These ingredients have been shown to be effective in soothing scalp psoriasis symptoms, making them a preferred treatment option for consumers.
Hypermarkets/supermarkets held the largest revenue share of 45.9% in 2023 as they offer a wide range of products, including medicated shampoos for various hair and scalp issues. Consumers can easily compare products on the same shelf. With established brands and trusted market presence, these outlets are often preferred by customers seeking reliable health products, including medicated shampoos.
Online distribution channels are expected to register the fastest CAGR of 7.1% over the forecast period. Online shopping offers consumers a convenient and accessible way to purchase medicated shampoos. From the comfort of their own homes, customers can browse a wide range of products, including those that may be embarrassing to purchase in-store. Online retailers often offer a broader selection and customer reviews, making it easier to make informed purchasing decisions.
North America medicated shampoo market dominated the global medicated shampoo market with a revenue share of 31.6% in 2023 driven by a high prevalence of scalp conditions such as dandruff, psoriasis, and seborrheic dermatitis. Strong distribution networks and competitive market presence also contribute to the region's dominance in the market.
The medicated shampoo market in U.S. held a significant market share in the North America medicated shampoo market in 2023. Rising consumer awareness about scalp health has driven growth in the country. Dermatologists and healthcare professionals emphasize the importance of proper scalp care, promoting medicated antidandruff shampoos over regular ones, leading to increased demand for medicated shampoos.
Europe medicated shampoo market held substantial market share in the global medicated shampoo market in 2023. Europe's regulatory framework for cosmetics and pharmaceutical products is notoriously stringent, with EMA and national health authorities enforcing rigorous standards for safety and efficacy. This rigorous approval process instills customer confidence, driving manufacturers to develop high-quality products that meet the region's exacting standards, ultimately contributing to a reputation for excellence in the medicated shampoo market.
The medicated shampoo market in Germany is poised for rapid growth, driven by the country's rich heritage in pharmacology and personal care production. The nation's well-developed R&D infrastructure and stringent regulatory framework have fostered innovation in dermatological treatments, positioning Germany as a hub for advancements in the medicated shampoo industry.
Asia Pacific medicated shampoo market is expected to register the fastest CAGR of 5.1% during the forecast period. Rising middle-class consumerism in countries such as China and India, driven by economic growth, is fueling demand for personal care products such as medicated shampoos. As consumers increasingly prioritize quality and efficacy, the desire for premium products that meet specific needs is stimulating market growth and development, presenting opportunities for businesses to capitalize on this trend.
The medicated shampoo market in China is poised for significant growth, driven by factors such as widespread education on personal hygiene, high prevalence of skin-related issues, and a diverse range of products available. The expansion of China's e-commerce sector has also enabled greater accessibility and convenience, further fueling market growth and expansion.
Some key companies in the medicated shampoo market include Procter & Gamble; Himalaya Wellness Company; and Johnson & Johnson Services, Inc.; among others. Competition in the market is expected to drive consolidation, with major players focusing on geographic expansion and customer base growth through product innovation, effective marketing, and strategic expansion.
Procter & Gamble Co., a global consumer goods manufacturer, offers a diverse portfolio of products across beauty, grooming, healthcare, and other categories. The company's extensive range of medicated shampoos targets various scalp and hair issues, catering to the needs of a diverse customer base.
Himalaya Wellness Company specializes in herbal care solutions for personal health and wellness. Its product portfolio includes dietary supplements, personal care products, and over-the-counter solutions. The company's medicated shampoo series addresses various hair and scalp concerns, providing effective solutions for customers.
The following are the leading companies in the medicated shampoo market. These companies collectively hold the largest market share and dictate industry trends.
In April 2024, epres launched its Healthy Hair Shampoo and Conditioner, utilizing patented Biodiffusion technology, which promises faster drying and continuous repair after drying, further enhancing its hair care product line.
In August 2023, Himalaya Wellness Company introduced two shampoos in sachet form, including a dandruff control shampoo with Aloe Vera and a hair fall control shampoo boasting Bhringaraja, as part of its strategy to expand its market reach and increase penetration.
Report Attribute |
Details |
Market size value in 2024 |
USD 15.87 billion |
Revenue forecast in 2030 |
USD 20.84 billion |
Growth rate |
CAGR of 4.6% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Treatment, distribution channel, region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, MEA |
Country scope |
U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Australia & New Zealand, Brazil, South Africa |
Key companies profiled |
Procter & Gamble; Himalaya Wellness Company; Johnson & Johnson Services, Inc.; Unilever; Henkel AG & Co. KGaA; Kao Corporation; Avalon Organics; Summers Laboratories, Inc.; Coty Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global medicated shampoo market report based on treatment, distribution channel, and region.
Treatment Outlook (Revenue, USD Million, 2018 - 2030)
Dandruff & Seborrheic Dermatitis
Psoriasis
Tinea Capitis
Head Lice
Allergic Reactions
Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
Hypermarkets / Supermarkets
Convenience Stores
Online
Other Distribution Channels
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Asia Pacific
China
India
Japan
South Korea
Australia & New Zealand
Central & South America
Brazil
Middle East & Africa
South Africa
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."